Regen BioPharma Inc Business Finance Contracts & Agreements

145 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
10% Promissory Note between Regen Biopharma, Inc. and Coventry Enterprises LLC dated September 4, 2024
Note Agreements
Regen BioPharma Inc
DE
2024
Promissory Note Between Regen BioPharma, Inc. and Zander Therapeutics, Inc. (10% Interest, $25,000, Due June 5, 2025)
Note Agreements
Regen BioPharma Inc
2024
Promissory Note Between Regen BioPharma, Inc. and Zander Therapeutics, Inc. (10% Interest, $15,000, Due May 3, 2025)
Note Agreements
Regen BioPharma Inc
2024
Convertible Promissory Note between Regen BioPharma, Inc. and Zander Therapeutics, Inc.
Note Agreements
Regen BioPharma Inc
CA
2023
License Assignment and Consent Agreement among Zander Therapeutics, Inc., Regen Biopharma, Inc., and KCL Therapeutics, Inc.
Assignment Agreements
Regen BioPharma Inc
CA
2023
Registration Rights Agreement between Regen Biopharma, Inc. and Coventry Enterprises, LLC (September 12, 2023)
Registration Rights Agreements
Regen BioPharma Inc
NV
2023
10% Promissory Note between Regen Biopharma, Inc. and Coventry Enterprises LLC dated September 12, 2023
Note Agreements
Regen BioPharma Inc
NV
2023
License Assignment and Consent Agreement among Zander Therapeutics, Regen Biopharma, and KCL Therapeutics (December 17, 2018)
Assignment Agreements
Regen BioPharma Inc
CA
2023
Convertible Promissory Note between Regen BioPharma, Inc. and Zander Therapeutics, Inc.
Note Agreements
Regen BioPharma Inc
CA
2023
5% Promissory Note between Regen Biopharma, Inc. and Coventry Enterprises LLC dated September 17, 2021
Note Agreements
Regen BioPharma Inc
NY
2021
Amendment to License and Assignment Agreement among Zander Therapeutics, KCL Therapeutics, and Regen BioPharma (April 2021)
Modification Agreements
Regen BioPharma Inc
2021
Amendment No. 1 to Convertible Promissory Note between Regen Biopharma, Inc. and Auctus Fund, LLC
Note Agreements
Regen BioPharma Inc
2019
8% Convertible Redeemable Note between Regen Biopharma, Inc. and LG Capital Funding, LLC (Due July 19, 2020)
Note Agreements
Regen BioPharma Inc
NY
2019
Regen Biopharma, Inc. 10% Convertible Redeemable Note Due July 19, 2020 (Adar Alef, LLC)
Note Agreements
Regen BioPharma Inc
NY
2019
Regen BioPharma, Inc. 10% Convertible Redeemable Note Due July 19, 2020 (with Odyssey Capital Funding LLC)
Note Agreements
Regen BioPharma Inc
NY
2019
Regen Biopharma, Inc. 10% Convertible Redeemable Note Agreement with Coventry Enterprises, LLC
Note Agreements
Regen BioPharma Inc
NY
2019
Collateralized Secured Promissory Note between Adar Alef, LLC and Regen Biopharma, Inc. dated January 22, 2019
Note Agreements
Regen BioPharma Inc
2019
10% Convertible Redeemable Note Due January 22, 2020 between Regen Biopharma, Inc. and ADAR ALEF, LLC
Note Agreements
Regen BioPharma Inc
NY
2019
10% Convertible Redeemable Note between Regen BioPharma, Inc. and ADAR ALEF, LLC, Due January 22, 2020
Note Agreements
Regen BioPharma Inc
NY
2019
Collateralized Secured Promissory Note between LG Capital Funding, LLC and Regen Biopharma, Inc. dated October 3, 2018
Note Agreements
Regen BioPharma Inc
2019
Regen BioPharma, Inc. 10% Convertible Redeemable Note Due October 11, 2019 (One44 Capital LLC)
Note Agreements
Regen BioPharma Inc
NY
2019
Regen BioPharma, Inc. 8% Convertible Redeemable Note with LG Capital Funding, LLC (Due October 3, 2019)
Note Agreements
Regen BioPharma Inc
NY
2019
Regen BioPharma, Inc. 8% Convertible Redeemable Note Due October 3, 2019 (LG Capital Funding, LLC)
Note Agreements
Regen BioPharma Inc
NY
2019
License Assignment and Consent Agreement among Zander Therapeutics, Inc., Regen Biopharma, Inc., and KCL Therapeutics, Inc.
Assignment Agreements
Regen BioPharma Inc
CA
2018
Convertible Promissory Note between Regen BioPharma, Inc. and Zander Therapeutics, Inc.
Note Agreements
Regen BioPharma Inc
CA
2018
Convertible Promissory Note between Regen BioPharma, Inc. and Caven Investments LLC dated July 11, 2018
Note Agreements
Regen BioPharma Inc
CA
2018
Convertible Promissory Note between Regen BioPharma, Inc. and Auctus Fund, LLC dated May 18, 2018
Note Agreements
Regen BioPharma Inc
MA
2018
12% Convertible Promissory Note between Regen Biopharma, Inc. and JSJ Investments Inc. dated February 26, 2018
Note Agreements
Regen BioPharma Inc
TX
2018
Convertible Promissory Note between Regen BioPharma, Inc. and Millennium Trust Co., LLC Custodian, Michael Ouyang IRA
Note Agreements
Regen BioPharma Inc
CA
2018
Convertible Promissory Note between Regen BioPharma, Inc. and Lender (February 2018)
Note Agreements
Regen BioPharma Inc
CA
2018
Regen BioPharma, Inc. $25,000 Convertible Promissory Note Agreement (January 24, 2018)
Note Agreements
Regen BioPharma Inc
CA
2018
Convertible Promissory Note between Regen BioPharma, Inc. and Lender (December 6, 2017)
Note Agreements
Regen BioPharma Inc
CA
2018
Convertible Promissory Note between Regen BioPharma, Inc. and Lender (January 24, 2018)
Note Agreements
Regen BioPharma Inc
CA
2018
Regen BioPharma, Inc. 8% Convertible Redeemable Note Due December 6, 2018 (GS Capital Partners, LLC)
Note Agreements
Regen BioPharma Inc
NY
2018
Securities Purchase Agreement between Regen BioPharma, Inc. and Coventry Enterprises, LLC (September 4, 2024)
Purchase Agreements
Regen BioPharma Inc
DE
2024
Common Stock Purchase Agreement between Regen BioPharma Inc. and Coventry Enterprises, LLC dated September 12, 2023
Purchase Agreements
Regen BioPharma Inc
NV
2023
Securities Purchase Agreement between Regen BioPharma, Inc. and Coventry Enterprises, LLC (September 12, 2023)
Purchase Agreements
Regen BioPharma Inc
NV
2023
Stock Purchase Agreement between Peiwen Yu and Sellers of Entest Group, Inc. Shares
Purchase Agreements
Regen BioPharma Inc
NY
2018
Unit Purchase Agreement between Regen Biopharma, Inc. and Purchaser (January 26, 2018)
Purchase Agreements
Regen BioPharma Inc
CA
2018
Unit Purchase Agreement between Regen Biopharma, Inc. and Purchaser (January 26, 2018)
Purchase Agreements
Regen BioPharma Inc
2018